Skip to main content

Table 4 Multivariate analysis of variables associated with overall survival in patients undergoing repeat TACE

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Overall cohort n = 292     
Variable Hazard Ratio Lower 95% CI Higher 95% CI P value
Baseline tumour number, 1, 2,3, > 3 1.18 1.03 1.36 0.020
Bilirubin post TACE 1 1.02 1.00 1.03 0.007
AFP ≥ 200 ng/ml post TACE 1 2.13 1.34 3.40 0.001
Decompensation post TACE 2 4.50 1.86 10.89 0.001